Inventor · disambiguated record
Frédéric Tangy
Also filed as: TANGY FREDERIC · TANGY FRÉDERIC · TANGY FRÉDÉRIC
36 granted patents·11 pending applications·166 citations·filing 2004–2022
97Inventor score
Top patents by PatentIndex Score
47 records- 0191US10793877B2Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositionsTANGY FREDERIC·Filed 2019·Granted Oct 6, 2020·5 cites·26 claims
- 0291US8337857B2Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infectionTANGY FREDERIC·Filed 2006·Granted Dec 25, 2012·11 cites·21 claims
- 0391US7556812B2Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applicationsPASTEUR INSTITUT·Filed 2005·Granted Jul 7, 2009·14 cites·5 claims
- 0490US8586364B2Cells and methodology to generate non-segmented negative-strand RNA virusesTANGY FREDERIC·Filed 2007·Granted Nov 19, 2013·12 cites·16 claims
- 0590US8343718B2Strain of SARS-associated coronavirus and applications thereofPASTEUR INSTITUT·Filed 2010·Granted Jan 1, 2013·22 cites·8 claims
- 0689US9701944B2Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositionsTANGY FREDERIC·Filed 2015·Granted Jul 11, 2017·5 cites·14 claims
- 0789US9012214B2Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositionsTANGY FRÉDÉRIC·Filed 2010·Granted Apr 21, 2015·15 cites·19 claims
- 0889US8853379B2Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infectionTANGY FREDERIC·Filed 2011·Granted Oct 7, 2014·9 cites·15 claims
- 0988US8859240B2Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applicationsTANGY FRÉDÉRIC·Filed 2009·Granted Oct 14, 2014·7 cites·14 claims
- 1087US10519466B2Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositionsTANGY FREDERIC·Filed 2018·Granted Dec 31, 2019·5 cites·17 claims
- 1187US9005925B2Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositionsTANGY FRÉDÉRIC·Filed 2008·Granted Apr 14, 2015·12 cites·13 claims
- 1282US9914937B2Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositionsTANGY FREDERIC·Filed 2015·Granted Mar 13, 2018·3 cites·12 claims
- 1381US7736850B2Strain of SARS-associated coronavirus and applications thereofPASTEUR INSTITUT·Filed 2004·Granted Jun 15, 2010·18 cites·5 claims
- 1478US11020473B2Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseasesPASTEUR INSTITUT·Filed 2017·Granted Jun 1, 2021·2 cites·19 claims
- 1577US8980634B2Reverse genetics of negative-strand RNA viruses in yeastMILED CHAOUKI·Filed 2009·Granted Mar 17, 2015·6 cites·30 claims
- 1676US9005961B2Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositionsTANGY FRÉDERIC·Filed 2004·Granted Apr 14, 2015·10 cites·11 claims
- 1773US12163150B2Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositionsTANGY FREDERIC·Filed 2020·Granted Dec 10, 2024·0 cites·9 claims
- 1873US10314905B2Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyPASTEUR INSTITUT·Filed 2018·Granted Jun 11, 2019·1 cites·6 claims
- 1973US9889193B2Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyPASTEUR INSTITUT·Filed 2014·Granted Feb 13, 2018·2 cites·6 claims
- 2073US9655961B2Recombinant measles virus expressing chikungunya virus polypeptides and their applicationsPASTEUR INSTITUT·Filed 2013·Granted May 23, 2017·3 cites·20 claims
- 2173US9023643B2Medicaments and methods for treating mesotheliomaGAUVRIT ANNE·Filed 2008·Granted May 5, 2015·2 cites·11 claims
- 2270US11034730B2Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infectionPASTEUR INSTITUT·Filed 2019·Granted Jun 15, 2021·1 cites·11 claims
- 2369US10980873B2Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyPASTEUR INSTITUT·Filed 2019·Granted Apr 20, 2021·0 cites·10 claims
- 2468US2021102220A1Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositionsTANGY FREDERIC·Filed 2020·Application pending·0 cites
- 2566US9579375B2Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infectionPASTEUR INSTITUT·Filed 2014·Granted Feb 28, 2017·0 cites·12 claims
- 2664US10227385B2Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infectionPASTEUR INSTITUT·Filed 2017·Granted Mar 12, 2019·0 cites·12 claims
- 2763US10316066B2Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infectionPASTEUR INSTITUT·Filed 2015·Granted Jun 11, 2019·1 cites·10 claims
- 2860US2024093233A1Measles-hiv or measles-htlv vaccineVIROXIS·Filed 2022·Application pending·0 cites
- 2959US2011236468A1Vaccine compositionsLORIN CLARISSE MARIE-MADELEINE·Filed 2009·Application pending·0 cites
- 3058US2006013826A1Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositionsTANGY FREDERIC·Filed 2004·Application pending·0 cites
- 3156US9499799B2Cells and methodology to generate non-segmented negative-strand RNA virusesPASTEUR INSTITUT·Filed 2013·Granted Nov 22, 2016·0 cites·22 claims
- 3256US2023235356A1An improved measles virus vaccine vector based on multiple tandem additional transcription units (atus)PASTEUR INSTITUT·Filed 2021·Application pending·0 cites
- 3354US8716013B2Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccineDESPRES PHILIPPE·Filed 2011·Granted May 6, 2014·0 cites·14 claims
- 3453US2023021583A1Measles-vectored covid-19 immunogenic compositions and vaccinesPASTEUR INSTITUT·Filed 2021·Application pending·0 cites
- 3552US11976305B2Lassa vaccinePASTEUR INSTITUT·Filed 2018·Granted May 7, 2024·0 cites·33 claims
- 3651US10300128B2Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptidesPASTEUR INSTITUT·Filed 2014·Granted May 28, 2019·0 cites·18 claims
- 3750US9682136B2Reverse genetics of negative-strand RNA viruses in yeastPASTEUR INSTITUT·Filed 2015·Granted Jun 20, 2017·0 cites·29 claims
- 3850US9636395B2Medicaments and methods for treating mesotheliomaPASTEUR INSTITUT·Filed 2015·Granted May 2, 2017·0 cites·4 claims
- 3950US2024000885A1Compositions and methods for targeting the interaction of host myo5b+d and coronavirus m proteinsUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 4049US11857616B2Recombinant measles virus expressing zika virus prM and E proteinsPASTEUR INSTITUT·Filed 2018·Granted Jan 2, 2024·0 cites·24 claims
- 4149US2009214589A1Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccineDESPRES PHILIPPE·Filed 2005·Application pending·0 cites
- 4246US2012082693A1Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strainVAN DER WERF SYLVIE·Filed 2011·Application pending·0 cites
- 4343US2011159480A1Cell-based screening assay to identify molecules that stimulate ifn-alpha/beta target genesPASTEUR INSTITUT·Filed 2009·Application pending·0 cites
- 4440US11351246B2Recombinant measles vaccine expressing hTERTInvectys SAS·Filed 2018·Granted Jun 7, 2022·0 cites·26 claims
- 4540US2023183739A1Recombinant measles virus expressing proteins of a plasmodium parasite and their applicationsPASTEUR INSTITUT·Filed 2019·Application pending·0 cites
- 4638US11160858B2Live recombinant measles-M2 virus—its use in eliciting immunity against influenza virusesPASTEUR INSTITUT·Filed 2016·Granted Nov 2, 2021·0 cites·16 claims
- 4727US9315482B2Derivatives useful as antiviral agentsVIDALAIN PIERRE-OLIVIER·Filed 2011·Granted Apr 19, 2016·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →